Infectious Diseases – Webinars and Online Events

This webinar will introduce a novel method for parent-of-origin-aware genomic analysis using the long-read capabilities of nanopore sequencing and single-cell DNA template strand sequencing to assign variants to each biological parent with 99% accuracy using only a blood research sample from the child.

Antibodies are ideal therapeutic biomolecules due to their ability to bind to a variety of targets with high affinity and specificity. Innovations in hybridoma and phage display technologies have enabled drug developers to exploit the natural diversity in antibodies, leading to the wide use of monoclonal antibodies.

In this webinar, Dr. Jonathan Schmitz will provide a broad overview of PCR in diagnostic microbiology, with particular emphasis on the challenges that can face the development of new assays and impact their clinical actionability. Many of these issues - while hardly unique to SARS-CoV-2- can be highlighted by the evolving dynamics of this virus over the past three years.

This webinar explores how the latest humanized mouse models are advancing infectious disease research by helping scientists evaluate drug candidates of interest.

In this webinar, our guest speakers will be discussing how to harness the full power of this disease-agnostic RNA platform, the key considerations needed for consistent, high-quality mRNA synthesis and how you can intensify manufacturing for rapid therapeutic production.

In this webinar, Dr. Angelo will showcase his research into understanding the evolving spatiotemporal network behind how immune tolerance develops in cancer, pregnancy and TB.

The polymerase chain reaction (qPCR) is firmly established as the method of choice for the detection of microbial agents in the areas of clinical, veterinary and agricultural diagnostics and food safety. The current pandemic has highlighted the critical importance of local, fast and specific testing for SARS-CoV-2. It should also act as a wake-up call for the threat posed by infectious diseases spreading because of climate change, increasing antibiotic resistance and the hazard of zoonotic transfer caused by human encroachment of animal habitats. We are working on new tests, protocol and reagents to achieve faster molecular diagnostic testing both for both laboratory based and POC applications. Our target of delivering a diagnostic test result within five minutes of sampling has the potential to lead to a paradigm shift in our approach to detecting and classifying microbial pathogens in preparation for the inevitable next pandemic

Here, Dr. Riglar will discuss ways that we are using synthetic biology to solve this problem, and our quest to develop non-invasive living engineered bacterial tools – smart probiotics – to help us understand and control the gut and gut microbiota.

RNA dependent RNA polymerase (RdRp), is essential in the RNA replication within the life cycle of the severely acute respiratory coronavirus-2 (SARS-CoV-2), causing the deadly respiratory induced sickness COVID-19.

In this webinar, our expert speaker, Vanessa Porter, will present her research into identifying and classifying genomic perturbations arising from HPV integration.